Results 161 to 170 of about 6,987 (195)

Clinical relevance of midkine as a biomarker predicting atherosclerotic risk factors in individuals with type-2 diabetes mellitus: a cross-sectional study. [PDF]

J Diabetes Metab Disord
Salman IN, Mohammed NUG, Shaban A, Abed BA, Ali Mutar S, Omran HH.   +5 more
europepmc   +1 more source

Prognostic and diagnostic effects of high serum midkine levels in patients with hepatocellular carcinoma. [PDF]

Oncol Lett
Okada R, Otsuka Y, Kajiwara Y, Maeda T, Ishii J, Kimura K, Matsumoto Y, Ito Y, Funahashi K, Shimada H.   +9 more
europepmc   +1 more source

Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer. [PDF]

PLoS One
Hao H, Maeda Y, Fukazawa T, Yamatsuji T, Takaoka M, Bao XH, Matsuoka J, Okui T, Shimo T, Takigawa N, Tomono Y, Nakajima M, Fink-Baldauf IM, Nelson S, Seibel W, Papoian R, Whitsett JA, Naomoto Y.   +17 more
europepmc   +1 more source

RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma. [PDF]

Asian Pac J Cancer Prev
Mamdouh S, Khorshed FEM, Hammad G, Magdy M, Abdelraouf A, Hemida E, Shemis M.   +6 more
europepmc   +1 more source

Exploring the potential function of high expression of <i>ANAPC1</i> in regulating ubiquitination in hepatocellular carcinoma. [PDF]

World J Gastrointest Oncol
Tang YX, Wu WZ, Zhou SS, Zeng DT, Zheng GC, He RQ, Qin DY, Huang WY, Chen JT, Dang YW, Tang YL, Chi BT, Zhan YT, Chen G.   +13 more
europepmc   +1 more source

Bioinformatics study of bortezomib resistance-related proteins and signaling pathways in mantle cell lymphoma. [PDF]

Transl Cancer Res
Zheng L, Shen Q, Fang G, Robertson IJ, Long Q.   +4 more
europepmc   +1 more source

Exploring drug resistance via intercellular crosstalk using spatial transcriptomics in high-grade serous ovarian carcinoma. [PDF]

NPJ Precis Oncol
Suzuki H, Yoshida K, Yokoi A, Suzuki K, Hirano Y, Kitagawa M, Asano-Inami E, Yoshihara M, Nagao Y, Tamauchi S, Yoshikawa N, Kajiyama H, Yamamoto Y.   +12 more
europepmc   +1 more source

Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer

Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
openaire